Splenic Marginal Zone Lymphoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Active, not recruiting
  • Adult Grade III Lymphomatoid Granulomatosis
  • +23 more
  • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
  • +2 more
  • Duarte, California
    City of Hope Medical Center
2022-02-16
Feb 16, 2022
M
Active, not recruiting
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +20 more
  • Scottsdale, Arizona
  • +1 more
2022-02-03
Feb 3, 2022
U
Recruiting
  • Mantle Cell Lymphoma
  • +5 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
2021-11-19
Nov 19, 2021
I
Recruiting
  • Marginal Zone Lymphoma
  • +2 more
  • Yvoir, Belgium
  • +36 more
2021-11-30
Nov 30, 2021
U
Active, not recruiting
  • Adult Grade III Lymphomatoid Granulomatosis
  • +71 more
  • Chicago, Illinois
  • +5 more
2021-10-08
Oct 8, 2021
K
Active, not recruiting
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +8 more
  • PI3K inhibitor BKM120
  • +3 more
  • Atlanta, Georgia
  • +1 more
2021-09-29
Sep 29, 2021
N
Terminated
  • Adult Grade III Lymphomatoid Granulomatosis
  • +116 more
  • brentuximab vedotin
  • +2 more
  • Chicago, Illinois
  • +2 more
2021-08-30
Aug 30, 2021
S
Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +67 more
  • Fludarabine phosphate
  • +8 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
2021-08-31
Aug 31, 2021
I
Completed
  • Splenic Marginal Zone Lymphoma
    • Bellinzona, Switzerland
      IOSI
    2021-06-04
    Jun 4, 2021
    B
    Completed
    • Adult Grade III Lymphomatoid Granulomatosis
    • +88 more
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    2021-04-14
    Apr 14, 2021
    R
    Completed
    • Adult Acute Lymphoblastic Leukemia in Remission
    • +58 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    2021-03-23
    Mar 23, 2021
    F
    Terminated
    • Adult Nasal Type Extranodal NK/T-cell Lymphoma
    • +32 more
    • indium In 111 anti-CD45 monoclonal antibody BC8
    • +2 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center/University of Washington
    2021-03-07
    Mar 7, 2021
    K
    Active, not recruiting
    • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
    • +9 more
    • BTK inhibitor PCI-32765
    • +5 more
    • Columbus, Ohio
      Ohio State University Medical Center
    2021-02-20
    Feb 20, 2021
    S
    Active, not recruiting
    • Adult Acute Lymphoblastic Leukemia in Remission
    • +46 more
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    2021-02-10
    Feb 10, 2021
    N
    Completed
    • Adult Nasal Type Extranodal NK/T-cell Lymphoma
    • +35 more
    • Akt inhibitor MK2206
    • laboratory biomarker analysis
    • Houston, Texas
      M D Anderson Cancer Center
    2020-10-14
    Oct 14, 2020
    M
    Completed
    • Adult Nasal Type Extranodal NK/T-cell Lymphoma
    • +18 more
    • Scottsdale, Arizona
    • +1 more
    2020-09-28
    Sep 28, 2020
    N
    Completed
    • Anaplastic Large Cell Lymphoma
    • +12 more
    • Iowa City, Iowa
    • +1 more
    2020-04-03
    Apr 3, 2020
    M
    Completed
    • Adult Nasal Type Extranodal NK/T-cell Lymphoma
    • +27 more
    • Scottsdale, Arizona
    • +2 more
    2020-03-02
    Mar 2, 2020
    F
    Completed
    • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
    • +99 more
    • alemtuzumab
    • +6 more
    • Denver, Colorado
    • +6 more
    2020-01-15
    Jan 15, 2020
    F
    Completed
    • Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
    • +76 more
    • fludarabine phosphate
    • +6 more
    • Tucson, Arizona
    • +10 more
    2020-01-17
    Jan 17, 2020
    F
    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +134 more
    • fludarabine phosphate
    • +6 more
    • Stanford, California
    • +9 more
    2020-01-15
    Jan 15, 2020
    M
    Completed
    • Cutaneous B-cell Non-Hodgkin Lymphoma
    • +15 more
    • dendritic cell vaccine therapy
    • +6 more
    • Rochester, Minnesota
      Mayo Clinic
    2020-01-13
    Jan 13, 2020